Intranasal immunization with genetically detoxified diphtheria toxin induces T cell responses in humans: enhancement of Th2 responses and toxin-neutralizing antibodies by formulation with chitosan.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Vaccine

• Publication date

  2004-02-25

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.VACCINE.2003.09.012PMID 15161067
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Protective Levels of Diphtheria-Neutralizing Antibody Induced in Healthy Volunteers by Unilateral Priming-Boosting Intranasal Immunization Associated with Restricted Ipsilateral Mucosal Secretory Immunoglobulin A

  2003cited by this paper
• Nasal vaccination: a non-invasive vaccine delivery method that holds great promise for the future.

  2001cited by this paper
• Chitosan as a novel nasal delivery system for vaccines.

  2001cited by this paper
• Immunomodulators and delivery systems for vaccination by mucosal routes.

  2001cited by this paper
• Immunization with Haemophilus influenzae type b-CRM(197) conjugate vaccine elicits a mixed Th1 and Th2 CD(4+) T cell cytokine response that correlates with the isotype of antipolysaccharide antibody.

  2001cited by this paper
• Induction of antigen-specific T cell responses in human volunteers after intranasal immunization with a whole-cell pertussis vaccine.

  2000cited by this paper
• Implications of the diphtheria epidemic in the Former Soviet Union for immunization programs.

  2000cited by this paper
• The sero-epidemiology of diphtheria in Western Europe

  2000cited by this paper
• A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM(197)) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal delivery.

  2000cited by this paper
• Phase 1 Evaluation of Intranasal Virosomal Influenza Vaccine with and without Escherichia coli Heat-Labile Toxin in Adult Volunteers

  1999cited by this paper
• Mucosal immunity and tolerance: relevance to vaccine development

  1999cited by this paper
• Distinct T‐cell subtypes induced with whole cell and acellular pertussis vaccines in children

  1998influential reference
• Intranasal booster vaccination against diphtheria and tetanus in man.

  1997cited by this paper
• The expanding universe of T-cell subsets: Th1, Th2 and more.

  1996cited by this paper
• Chitin biotechnology applications.

  1996cited by this paper
• New Generation Vaccines

  1990cited by this paper

• Chitosan nanoparticles for brain targeted nose-to-brain drug delivery in neurodegenerative disease: a comprehensive exploration of advances, limitations and future prospects.

  2026cites this paper
• Harnessing the immunomodulatory potential of chitosan and its derivatives for advanced biomedical applications.

  2025cites this paper
• Recent advances in vaccine adjuvants: from lab to clinic.

  2025cites this paper
• Applications of Chitosan in Prevention and Treatment Strategies of Infectious Diseases

  2024cites this paper
• Exploration of chitosan and its modified derivatives as vaccine adjuvant: A Review

  2024cites this paper
• Efficiency of Chitosan Nanocarriers in Vaccinology for Mucosal Immunization

  2023cites this paper
• Advances in intranasal vaccine delivery: A promising non-invasive route of immunization

  2023cites this paper
• Chitosan Nanoparticles-Based Cancer Drug Delivery: Application and Challenges

  2023cites this paper
• Recent advances in respiratory immunization: A focus on COVID-19 vaccines

  2023cites this paper
• Applications of chitosan derivatives as adjuvant for nanoparticles based vaccines.

  2022cites this paper
• Nasal Administration of M2e/CpG-ODN Encapsulated in N-Trimethyl Chitosan (TMC) Significantly Increases Specific Immune Responses in a Mouse Model.

  2022cites this paper
• Expression of full and fragment-B of diphtheria toxin genes in Escherichia coli for generating of recombinant diphtheria vaccines

  2022cites this paper
• Saponin and chitosan-based oral vaccine against viral haemorrhagic septicaemia virus (VHSV) provides protective immunity in olive flounder (Paralichthys olivaceus).

  2022cites this paper
• Intranasal vaccine: factors to consider in research and development.

  2021cites this paper
• Iron nanoparticles as novel vaccine adjuvants.

  2021cites this paper
• Abated immune responses against recombinant hepatitis-b vaccine by chitin in mice

  2021cites this paper
• An Overview on Chitosan-Based Adjuvant/Vaccine Delivery Systems

  2021cites this paper
• Chitosan-based particulate systems for drug and vaccine delivery in the treatment and prevention of neglected tropical diseases

  2020cites this paper
• Alternative vaccine delivery methods

  2020cites this paper
• Current status and future of chitosan in drug and vaccine delivery

  2020cites this paper
• Chitosan-based particulate systems for drug and vaccine delivery in the treatment and prevention of neglected tropical diseases

  2020cites this paper
• Mucoadhesive Multiparticulate Drug Delivery Systems: An Extensive Review of Patents

  2019cites this paper
• Evaluation of the Effects of Chitosan on Immune Responses due to Infectious Bursal Disease Virus (IBDV) Vaccine in Chicken

  2019cites this paper
• EGFR nanovaccine in lung cancer treatment

  2019cites this paper
• Mucosal Vaccine Approaches for Prevention of HIV and SIV Transmission.

  2019cites this paper
• Chitin: A "Hidden Figure" in the Fungal Cell Wall.

  2019cites this paper
• Current and New Approaches for Mucosal Vaccine Delivery

  2019cites this paper
• Intranasal immunization with aluminum salt‐adjuvanted dry powder vaccine

  2018cites this paper
• Intranasal immunization with dry powder vaccines

  2018cites this paper
• Effects of chitosan and chitosan N-acetylcysteine solutions on conjunctival epithelial cells

  2018cites this paper
• Polysaccharides as vaccine adjuvants.

  2018cites this paper
• Nasal vaccination with r4M2e.HSP70c antigen encapsulated into N-trimethyl chitosan (TMC) nanoparticulate systems: Preparation and immunogenicity in a mouse model.

  2018cites this paper
• Tumor-Associated Tertiary Lymphoid Structures: Gene-Expression Profiling and Their Bioengineering

  2017cites this paper
• Development of an effective delivery system for intranasal immunization against Mycobacterium tuberculosis ESAT-6 antigen

  2017cites this paper
• Recent advances in engineered chitosan-based nanogels for biomedical applications.

  2017cites this paper
• 4.24 Biomaterials in Vaccine and Immunotherapy

  2017cites this paper
• Technologies to Improve Immunization

  2017cites this paper
• Nasal nanovaccines.

  2017cites this paper
• Nasal-nanotechnology: revolution for efficient therapeutics delivery

  2016cites this paper
• Adjuvants: Classification, Modus Operandi, and Licensing

  2016cites this paper
• Novel particulate BCG-loaded delivery system for mucosal immunization against tuberculosis

  2016cites this paper
• Protective effect of a recombinant VHSV-G vaccine using poly(I:C) loaded nanoparticles as an adjuvant in zebrafish (Danio rerio) infection model.

  2016cites this paper
• Introduction to Molecular Vaccinology

  2016cites this paper
• Comparative Immunogenicity of HIV-1 gp140 Vaccine Delivered by Parenteral, and Mucosal Routes in Female Volunteers; MUCOVAC2, A Randomized Two Centre Study

  2016cites this paper
• SiRNA/DOX lodeded chitosan based nanoparticles: Development, Characterization and in vitro evaluation on A549 lung cancer cell line.

  2016cites this paper
• Effect of Experimental Parameters on Alginate/Chitosan Microparticles for BCG Encapsulation

  2016cites this paper
• Porous maltodextrin nanoparticles for the intranasal delivery of vaccines

  2016cites this paper
• Molecular Weight-Dependent Immunostimulative Activity of Low Molecular Weight Chitosan via Regulating NF-κB and AP-1 Signaling Pathways in RAW264.7 Macrophages

  2016cites this paper
• InCVAX--a novel strategy for treatment of late-stage, metastatic cancers through photoimmunotherapy induced tumor-specific immunity.

  2015cites this paper
• Chapter 58 – Respiratory Bacterial Vaccines

  2015cites this paper
• Immunostimulative Activity of Low Molecular Weight Chitosans in RAW264.7 Macrophages

  2015cites this paper
• Evaluation of mucosal adjuvants and immunization routes for the induction of systemic and mucosal humoral immune responses in macaques

  2015cites this paper
• Intravesical chitosan/interleukin-12 immunotherapy induces tumor-specific systemic immunity against murine bladder cancer

  2015cites this paper
• Chitosan-based vaccine adjuvants: incomplete characterization complicates preclinical and clinical evaluation

  2015cites this paper
• Alginate coated chitosan microparticles mediated oral delivery of diphtheria toxoid. Part A. Systematic optimization, development and characterization.

  2015cites this paper
• Development and Evaluation of Novel Vaccination Strategies for Campylobacter Control in Poultry

  2015cites this paper
• Utilization of a model vaccination system to evaluate the immunostimulatory characteristics of LicKM, a novel carrier molecule

  2015cites this paper
• Chitosan-Based Adjuvants

  2014cites this paper
• Chitosan-based systems for intranasal immunization against foot-and-mouth disease

  2014cites this paper
• Evaluation of safety and efficacy as an adjuvant for the chitosan-based vaccine delivery vehicle ViscoGel in a single-blind randomised Phase I/IIa clinical trial.

  2014cites this paper
• Novel influenza virus vectors expressing Brucella L7/L12 or Omp16 proteins in cattle induced a strong T-cell immune response, as well as high protectiveness against B. abortus infection.

  2014cites this paper
• Safety of the novel vector vaccine against Brucella abortus based on recombinant influenza viruses expressing Brucella L7/L12 and OMP16 proteins, in cattle

  2014cites this paper
• Chitosan and Low Molecular Weight Chitosan: Biological and Biomedical Applications

  2014cites this paper
• Immunoadjuvant Efficacy of N-Carboxymethyl Chitosan for Vaccination via Dendritic Cell Activation

  2014cites this paper
• Mannose-modified chitosan microspheres enhance OprF-OprI-mediated protection of mice against Pseudomonas aeruginosa infection via induction of mucosal immunity

  2014cites this paper
• Approaches to tuberculosis mucosal vaccine development using nanoparticles and microparticles: a review.

  2014cites this paper
• Evaluation and characterisation of A and B fragments of Corynebacterium diphtheriae toxin towards recombinant diphtheria vaccine.

  2013cites this paper
• IMMUNOBIOLOGY OF DIPHTHERIA. IMMUNOBIOLOGY OF DIPHTHERIA. RECENT APPROACHES FOR THE PREVENTION, RECENT APPROACHES FOR THE PREVENTION, DIAGNOSIS, AND TREATMENT OF DISEASE DIAGNOSIS, AND TREATMENT OF DISEASE

  2013cites this paper
• Immunobiology of diphtheria. Recent approaches for the prevention, diagnosis, and treatment of disease

  2013cites this paper
• Chitosan and Chitosan Derivatives for Mucosal Delivery of Biopharmaceutical Drugs

  2013cites this paper
• Role of chitosan co-formulation in enhancing interleukin-12 delivery and antitumor activity.

  2013cites this paper
• Adhesive microbeads for the targeting delivery of anticaries agents of vegetable origin.

  2013cites this paper
• Chitosans for delivery of nucleic acids

  2013influential citation
• Disparate Activation of the Inflammasome by Chitin and Chitosan: A Dissertation

  2013cites this paper
• Chitin, Chitosan, and Glycated Chitosan Regulate Immune Responses: The Novel Adjuvants for Cancer Vaccine

  2013cites this paper
• Vaccine adjuvants: key tools for innovative vaccine design.

  2013cites this paper
• New insights in mucosal vaccine development.

  2012cites this paper
• Towards tailored vaccine delivery: needs, challenges and perspectives.

  2012cites this paper
• Preclinical and Clinical Use of Chitosan and Derivatives for Biopharmaceuticals: From Preclinical Research to the Bedside

  2012cites this paper
• Applications of Nanotechnology in Bladder Cancer Therapy

  2012cites this paper
• Chitosan‐Based Delivery Systems for Mucosal Vaccination

  2012cites this paper
• Chitosan-based delivery systems for mucosal vaccines

  2012cites this paper
• Dry powder vaccines for mucosal administration: critical factors in manufacture and delivery.

  2011cites this paper
• In vivo efficacy of a chitosan/IL-12 adjuvant system for protein-based vaccines.

  2011cites this paper
• Chitosan but Not Chitin Activates the Inflammasome by a Mechanism Dependent upon Phagocytosis*

  2011cites this paper
• Re-formulating drugs and vaccines for intranasal delivery: maximum benefits for minimum risks?

  2011cites this paper
• Biochemical and biological characteristics of cross-reacting material 197 ( CRM 197 ) , a non-toxic mutant of diphtheria toxin : Use as a conjugation protein in vaccines and other potential clinical applications

  2011cites this paper
• Biochemical and biological characteristics of cross-reacting material 197 CRM197, a non-toxic mutant of diphtheria toxin: use as a conjugation protein in vaccines and other potential clinical applications.

  2011cites this paper
• eview ew insights in mucosal vaccine development

  2011cites this paper
• The Evolution and Value of Diphtheria Vaccine

  2011cites this paper
• Strategy of oral vaccination by polymeric nanoparticles : M cell targeting or bioadhesion

  2011cites this paper
• Chitosan-Based Particulate Systems for Non-Invasive Vaccine Delivery

  2011cites this paper
• Microneedle-based transcutaneous immunisation in mice with TMC adjuvanted diphtheria toxoid formulations

  2010cites this paper
• Microneedle-based transcutaneous immunisation in mice with TMC adjuvanted diphtheria toxoid formulations

  2010cites this paper
• Intratumoral Immunotherapy of Established Solid Tumors With Chitosan/IL-12

  2010cites this paper
• Novel Delivery Systems for Nasal Adminstration of Anthrax Vaccine

  2010cites this paper
• Microneedle-Based Transcutaneous Immunisation in Mice with N-Trimethyl Chitosan Adjuvanted Diphtheria Toxoid Formulations

  2010cites this paper
• Bioadhesive delivery systems for mucosal vaccine delivery

  2010cites this paper
• Mucosal adjuvants.

  2010cites this paper
• Progress in chitosan-based vaccine delivery systems

  2010cites this paper